This study investigates carcinoid syndrome. It focuses on evaluating the safety and effectiveness of an investigational medication in adults with this condition.
The study will evaluate the overall safety and how well the investigational medication works in general terms. It will also look at how the body processes the medication.
- Who can participate: Adults 18 and older with symptoms of flushing and confirmed neuroendocrine tumors can join.
- Study details: Participants will take an investigational medication or placebo. A placebo is an inactive substance that looks like the investigational medicine but does not contain any medicine.